Connect
← Return to New research on length of ADT therapy for patients with RT
Discussion
New research on length of ADT therapy for patients with RT
Prostate Cancer | Last Active: 7 hours ago | Replies (41)Comment receiving replies
@jamie1957 I only wish I could give you the correct answer! I guess it comes down to which genomic test is more reliable- Decipher or ArteraAI.
Many out there would say NO to ADT but pessimists like me might want it for 4-6 months, like just to squeeze out a few more percentage points in my favor.
Also, your surgical pathology, Gleason score and overall volume should probably be considered.
My margins were negative, even though I had a ‘tiny’ break in the capsule. But what is tiny to a few PCa cells?
Good luck with a tough decision.
Phil
Replies to "@jamie1957 I only wish I could give you the correct answer! I guess it comes down..."
Connect
@heavyphil I hear you Phil. I wasn't going to do it after consulting with Dr Scholz and he felt I didn't need ADT. He said it would only add 5-8% to my treatment success. This was after Top docs at COE's Univ ofPenn & Fox Chase both recommended ADT because of high PSA (both going by NIH guidelines). What convinced me to do it was when I consulted with Dr Chang and told him what Dr Scholz said he put things in perspective and said in the prostate treatment world 8% is a lot! His thoughts were my treatment plan of HDR Brachy and SBRT is a very aggressive treatment and probably don't need ADT but a short course 4-6 months would still be beneficial.